StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.48−0.17 (-4.79%)

Close on Nov 13, 2026Market cap $25.64MP/E –Yield –

Immutep cash

Cash and short-term investments held at the end of each period.

Immutep's cash was A$63.67M at Jun 30, 2026. For fiscal 2026 it was A$63.67M, down 5.5% from the year before. Over ten years it grew 11.8% a year on average. The highest annual figure on record is A$161.79M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$63.67M-5.5%
FY2025Jun 30, 2025A$67.41M-58.3%
FY2024Jun 30, 2024A$161.79M+31.1%
FY2023Jun 30, 2023A$123.42M+54.3%
FY2022Jun 30, 2022A$80.00M+32.0%
FY2021Jun 30, 2021A$60.59M+130.2%
FY2020Jun 30, 2020A$26.32M+58.9%
FY2019Jun 30, 2019A$16.57M-29.4%
FY2018Jun 30, 2018A$23.48M+91.8%
FY2017Jun 30, 2017A$12.24M-41.4%
FY2016Jun 30, 2016A$20.88M+208.9%
FY2015Jun 30, 2015A$6.76M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026A$63.67M-20.4%
Q4 FY2025CQ2 2025Jun 30, 2025A$67.41M+11.2%
Q4 FY2024CQ2 2024Jun 30, 2024A$161.79M+514.7%
Q4 FY2023CQ2 2023Jun 30, 2023A$123.42M+644.9%
Q4 FY2022CQ2 2022Jun 30, 2022A$80.00M+240.8%
Q4 FY2021CQ2 2021Jun 30, 2021A$60.59M+395.2%
Q4 FY2020CQ2 2020Jun 30, 2020A$26.32M+26.1%
Q4 FY2019CQ2 2019Jun 30, 2019A$16.57M+145.1%
Q4 FY2018CQ2 2018Jun 30, 2018A$23.48M–
Q4 FY2017CQ2 2017Jun 30, 2017A$12.24M–
Q4 FY2016CQ2 2016Jun 30, 2016A$20.88M–
Q4 FY2015CQ2 2015Jun 30, 2015A$6.76M–

More Immutep figures

See a number that looks wrong?